跳至主要内容
临床试验/NCT03507140
NCT03507140已完成不适用

Biliary and Intestinal Microbiota Study in Liver Transplanted Patients

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2019年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
1
主要终点
Comparison of the relative abundance of pathobionts and symbionts before and 6 months after liver transplantation, in the bile of recipients.

研究概览

简要总结

Many studies describe the relationship between microbiota alteration and the occurrence of metabolic, alcoholic or inflammatory liver diseases. Nevertheless, the modifications of microbiota during liver transplantation (LT) as well as its implication are poorly studied. Similarly, only the intestinal microbiota is studied in this context, and no data are available on the biliary microbiota, even if it is known that bile microbiota can interfere with hepatobiliary diseases.

This study proposes a clinical and biological in-depth follow-up with multiple sampling of liver transplanted patients to study biliary and intestinal microbiota alterations along LT, as well as bile acids metabolism in corresponding fluids.

Indeed, in recipient samples as saliva, blood, urine, and feces can be taken before LT, and surgeons can easily perform bile sampling during LT. In donors all samples can be taken during liver removal. This offers the opportunity to have a microbiotic landscape of individuals without liver disease (donor), and patients suffering from a chronic liver disease or a liver cancer before and after transplantation.

Also, in Grenoble University hospital, in case of biliary anastomotic incongruence, a biliary stent is placed during LT in 60% of recipients. This stent is removed by endoscopic retrograde cholangiopancreatography (ERCP) within 6 months after LT, offering a second opportunity to obtain bile samples in transplanted patients, after the early post-LT period. Patients who do not require a biliary stent will also be included for the study of secondary objectives, as intestinal microbiota is very poorly characterized in liver transplanted patients too. A portion of the patients without biliary stent, may also develop an anastomotic biliary stricture requiring an ERCP. If this ERCP is realized within the follow-up period of the study, the patient will also be included in the primary objective of the study.

These multiple and sequential samples will allow a complete analysis of microbiota changes in LT patients and aim to answer to 3 questions:

  1. What are the modifications of intestinal and biliary microbiomes during LT?
  2. What is the influence of bile acids' composition on intestinal and biliary microbiota?
  3. What are the relationships between microbiome alterations and the emergence of LT complications?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recipients:
  • Age ≥ 18 years old
  • Absence of LT contraindications
  • Patient undergoing liver transplantation
  • Patient legally able to give written consent.
  • Person affiliated to social security
  • Cadaveric-donor liver transplantation

排除标准

  • Living-related liver transplantation
  • LT contraindications
  • All subjects protected by articles L1121-5 and L1121-8 of French public health law (Subject under administrative or judicial control, person who are protected under the act, person hospitalized without their consent, prisoners and pregnant or breast-feeding women).

结局指标

主要结局

Comparison of the relative abundance of pathobionts and symbionts before and 6 months after liver transplantation, in the bile of recipients.

时间窗: During LT and 6 months after LT

Beneficial bacterias/pathobionts ratio before and 6 months after liver transplantation in the bile of recipients.

次要结局

  • Study the correlation between bile microbiota of donors and recipients after LT.(During LT and 6 months after LT)
  • Comparison of the relative abundance of pathobionts and beneficial bacteria at the time, and 6 months after liver transplantation, in the feces of recipients.(Before LT (6 months maximum) and 6 months after LT)
  • Study the relationships between microbiota and the emergence of LT complications (post LT infections, acute liver allograft reject, etc).(Before LT (6 months maximum) and 6 months after LT)
  • Comparison of fecal microbial diversity before, and 6 months after liver transplantation, in LT recipients.(Before LT (6 months maximum) and 6 months after LT)
  • Study the correlation between fecal microbiota of donors and recipients after LT.(Before LT (6 months maximum) and 6 months after LT)
  • Study the relationships between bile microbiota changes and intestinal microbiota modifications in recipients, before and after LT.(Before LT (6 months maximum) and 6 months after LT)
  • Study the modifications of bile acid profiles in recipients between before and after LT.(Before LT (6 months maximum) and 6 months after LT)
  • Biobanking of blood, saliva, bile, feces and urine for further analyses such as metabolomic studies on blood, urine and feces metagenomic studies on saliva, and immunomonitoring on blood.(Before LT (6 months maximum) and 6 months after LT)
  • Comparison of bile microbial diversity at the time, and 6 months after liver transplantation, in LT recipients.(During LT and 6 months after LT)
  • Study the influence of bile acids'composition on bile microbiota along transplantation.(Before LT (6 months maximum) and 6 months after LT)
  • Study the influence of bile acids' composition on intestinal microbiota along transplantation.(Before LT (6 months maximum) and 6 months after LT)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Microbiota Study in Liver Transplanted Patients | 临床试验